Closed-loop bioelectronic regulation of engineered secretory cell systems is challenging because electric-field (EF) stimulation acts indirectly through transcription-factor activation, in the presence of delayed, nonlinear, and noisy intracellular dynamics, sparse measurements, and constrained burst-based actuation. We develop a framework for robust closed-loop endocrine regulation in electrically stimulated engineered cell factories, illustrated through extracellular thyroid hormone production in engineered thyroid-like cells. The plant is modeled by a control-oriented ODE formulation combining a reduced mechanistic pathway, an EF-responsive Hill module, and a linear-chain Erlang cascade representing distributed intracellular delay. On this basis, we design a sampled-data adaptive proportional-integral-derivative (PID) controller with derivative filtering, anti-windup, saturation and rate limits, and hysteretic band-locking, together with a robust adaptive extension that accounts for parameter mismatch, sensor noise and bias, actuator mismatch, delay/jitter, and exogenous rhythmic disturbance through a scenario-based risk-aware update. We provide local sampled-data input-to-state stability interpretations for both APID and RAPID, showing that, under standard local Lyapunov and bounded-disturbance conditions, the sampled tracking error is ultimately bounded by a disturbance-dependent constant. In silico experiments demonstrate sustained regulation of extracellular across prescribed targets despite significant uncertainty.

生成讲解博客的中文版本

生成AI智能校验的中文版本